Postpolypectomy Haemorrhage
Cross-source consensus on Postpolypectomy Haemorrhage from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Other
Other
Highlighted claims
- The trial primary outcome is clinically significant postpolypectomy haemorrhage within 30 days. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- Postpolypectomy haemorrhage is the primary adverse event of colorectal polypectomy. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- Anticoagulated patients have reported postpolypectomy haemorrhage incidence of 10% to 20%. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- Postpolypectomy haemorrhage typically occurs a median of 4 to 7 days after the procedure. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM
- Most postpolypectomy haemorrhages are mild or moderate, and many resolve without colonoscopy. — Temporary interruption versus maintenance of anticoagulation in polypectomy of colorectal lesions: study protocol for a multicentre randomised non-inferiority clinical trial POLYPHEM